Anti‐Inflammatory effects of low‐level laser therapy (660 nm) in the early phase in carrageenan‐induced pleurisy in rat

Lasers in Surgery and Medicine - Tập 40 Số 7 - Trang 500-508 - 2008
Emerson Soldateli Boschi1, Carlos Eduardo Leite1, Vasyl Custódio Saciura1, Eduardo Caberlon1, Adroaldo Lunardelli1, Shanna Bitencourt1, Denizar Alberto da Silva Melo1, Jarbas Rodrigues de Oliveira2
1Laboratório de Pesquisa em Biofísica Celular e Inflamação, Pontifícia Universidade Católica do Rio Grande do Sul (PUCRS), Av. Ipiranga 6681 prédio 12C sala 263, CEP 90619-900 Porto Alegre, RS, Brazil
2Laboratório de Pesquisa em Biofísica e Inflamação, Pontifícia Universidade Católica do Rio Grande do Sul, Av. Ipiranga 6681 prédio 12C sala 263, CEP 90619‐900 Porto Alegre, RS, Brazil.

Tóm tắt

AbstractBackground and ObjectiveIn the classic model of pleurisy there is little evidence about the anti‐inflammatory effects of low‐level laser therapy (LLLT) as well the dosage characteristics, such as wavelength, total energy, number and pattern of treatment. In this study we investigated the potential effects of LLLT on modulating the pro‐inflammatory and anti‐inflammatory mediators of acute inflammation in a rat pleurisy model.Study Design/Materials and MethodsA sample of 48 female Wistar rats were divided into control and experiential groups. An inflammation was induced by carrageenan (0.2 ml) injected into the pleural cavity. At 1, 2, and 3 hours after induction a continuous wave (20 mW) diode laser of the InGaAlP (660 nm) type was used in the four laser groups with different doses and treatment patterns. One group received a single dose of 2.1 J and the other three groups received a total energy of 0.9, 2.1, and 4.2 J. Four hours later the exudate volume, total and differential leukocytes, protein concentration, NO, IL‐6, IL‐10, TNF‐α, and MCP‐1 were measured from the aspirated liquid.ResultsAll the treatment patterns and quantity of energy studied show significant reduction of the exudate volume (P<0.05). Using energy of 0.9 J only NO, IL‐6, MCP‐1 and IL‐10 are significantly reduced (P<0.05). On the other hand, higher energies (2.1 and 4.2 J) significantly reduce all variables independently of the treatment pattern. The neutrophil migration has a straight correlation with the TNF‐α (r = 0.551) and NO (r = 0.549) concentration.ConclusionsLLLT—660 nm induced an anti‐inflammatory effect characterized by inhibition of either total or differential leukocyte influx, exudation, total protein, NO, IL‐6, MCP‐1, IL‐10, and TNF‐α, in a dose‐dependent manner. Under these conditions, laser treatment with 2.1 J was more effective than 0.9 and 4.2 J. Lesers Surg. Med. 40:500–508, 2008. © 2008 Wiley‐Liss, Inc.

Từ khóa


Tài liệu tham khảo

10.1016/S1043-6618(02)00255-4

10.1016/S0024-3205(00)00827-4

Vinegar R, 1982, Pathway of onset, development, and decay of carrageenan pleuresy in the rat, Fed Proc, 41, 2588

10.1016/S0196-9781(99)00086-8

10.1016/j.lfs.2006.01.022

10.1097/00003246-200004001-00003

10.1152/ajplung.00405.2003

10.1634/stemcells.19-5-388

10.1006/cyto.1998.0376

Utsunomiya I, 1991, Sequential appearance of IL‐1 and IL‐6 activities in rat carrageenin‐induced pleurisy, J Immunol, 147, 1803, 10.4049/jimmunol.147.6.1803

10.1006/cyto.2001.0980

10.1378/chest.117.4.1162

10.1172/JCI1368

Davies NM, 2000, Detection and, prevention of NSAID‐induced enteropathy, J Pharm Sci, 3, 137

10.1016/S1590-8658(02)80234-1

Vladimirov YA, 2004, Photobiological principles of therapeutic applications of laser radiation, Rev Biochem, 69, 81

Tunér J, 2002, Laser therapy: Clinical practice and scientific background

10.1089/pho.2006.24.33

10.1034/j.1600-0722.2000.00783.x

10.1016/j.jphotobiol.2004.03.002

10.1089/pho.2005.23.377

10.1562/2005-02-28-RA-450

10.1007/s00011-007-6211-6

10.1016/S0196-9781(98)00170-3

10.1016/j.niox.2004.12.003

10.1016/j.phrs.2004.04.011

10.1007/s00011-006-0008-x

10.3181/00379727-111-27849

10.1111/j.1476-5381.1996.tb15475.x

10.1016/j.phrs.2004.01.011

10.1016/S0041-0101(02)00238-6

10.1152/japplphysiol.01318.2005

10.1016/1011-1344(89)80088-0

10.1109/JQE.1987.1073236

10.1016/S0006-2952(01)00586-X

10.1136/bjsm.2005.020842

10.1002/lsm.20148